APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L207. A total of 24 filers reported holding APTEVO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $58 | -50.4% | 175,980 | +119.5% | 0.00% | – |
| Q2 2023 | $117 | +4.5% | 80,186 | +45.8% | 0.00% | – |
| Q1 2023 | $112 | -26.3% | 54,986 | -16.0% | 0.00% | – |
| Q4 2022 | $152 | -99.9% | 65,486 | -4.2% | 0.00% | – |
| Q3 2022 | $208,000 | -16.8% | 68,386 | -2.1% | 0.00% | – |
| Q2 2022 | $250,000 | -27.7% | 69,886 | +18.7% | 0.00% | – |
| Q1 2022 | $346,000 | -36.0% | 58,886 | -14.3% | 0.00% | -100.0% |
| Q4 2021 | $541,000 | -75.6% | 68,686 | -52.1% | 0.00% | -66.7% |
| Q3 2021 | $2,214,000 | -38.3% | 143,419 | -10.3% | 0.00% | -25.0% |
| Q2 2021 | $3,587,000 | -43.8% | 159,923 | -23.6% | 0.00% | -50.0% |
| Q1 2021 | $6,385,000 | -31.5% | 209,223 | -17.8% | 0.01% | -20.0% |
| Q4 2020 | $9,325,000 | +318.9% | 254,423 | -13.1% | 0.01% | +400.0% |
| Q3 2020 | $2,226,000 | +16.9% | 292,867 | +28.5% | 0.00% | 0.0% |
| Q2 2020 | $1,904,000 | +184.2% | 227,967 | +26.0% | 0.00% | +100.0% |
| Q1 2020 | $670,000 | – | 180,966 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1,760,000 | $64,504,000 | 9.85% |
| Stonepine Capital Management, LLC | 18,280 | $670,000 | 0.51% |
| Ghost Tree Capital, LLC | 50,000 | $1,833,000 | 0.41% |
| Anson Funds Management LP | 45,462 | $1,666,000 | 0.34% |
| RTW INVESTMENTS, LP | 288,236 | $10,564,000 | 0.18% |
| Dynamic Technology Lab Private Ltd | 13,202 | $484,000 | 0.08% |
| Alyeska Investment Group, L.P. | 49,601 | $1,818,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11,493 | $421,000 | 0.02% |
| PURA VIDA INVESTMENTS, LLC | 8,203 | $301,000 | 0.01% |
| Renaissance Technologies | 254,423 | $9,325,000 | 0.01% |